(No ratings)
Dr. Linda A. Dimeglio, MD is a pediatric endocrinologist in Indianapolis, IN specializing in pediatric endocrinology and general practice. Dr. Linda A. Dimeglio, MD is affiliated with Riley Pediatric Diabetes & Endocrinology - Riley Outpatient Center.
She has a state license in Indiana.
Licensed In: Indiana
Dr. Linda A. Dimeglio, MD is associated with these hospitals and organizations:
Dr. Linda A. Dimeglio, MD appears to accept the following insurance providers: Aetna Medicare Advantage, Sagamore Health Network, MultiPlan/PHCS, Humana Medicare Advantage PPO, Managed Health Services Medicare Advantage (Allwell), Lutheran Preferred/Three Rivers Preferred, Aetna, UnitedHealthcare, UnitedHealthcare Community Plan Indiana PathWays for Aging, Humana, Cigna, Anthem, Coventry/First Health, Community Health Alliance, Indiana University Health Workers Compensation, Encore, Parkview Signature Care PPO (Excludes Allen County), Deaconess OneCare, Encore Elite, Managed Health Services Hoosier Healthwise, Indiana University Workers Compensation, Physicians Health Plan of Northern Indiana (PHP) (Allen County), Managed Health Services Healthy Indiana Plan, CareSource Hoosier Healthwise, Encore Combined, CareSource, VA Community Care Network, Encore Workers Compensation, Managed Health Services Hoosier Care Connect, CareSource Marketplace, Managed Health Services (MHS), CareSource Healthy Indiana Plan, Point Comfort Unaccompanied Children Program, Managed Health Services Marketplace, Community Health Network Employee Plan, Suburban Health Organization (SHO), Select Health and Zing Health.
According to our sources, Dr. Linda A. Dimeglio, MD accepts the following insurance providers:
Dr. Linda A. Dimeglio, MD does not have any reviews yet, be the first to leave a review of Dr. Linda A. Dimeglio, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Linda A. Dimeglio, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| SANOFI-AVENTIS U.S. LLC |
$29,397
NO PRODUCT DISCUSSED $591 |
$28,806 |
||||
|---|---|---|---|---|---|---|
| Eli Lilly and Company |
$26,896
HUMALOG $1,353 |
GLUCAGON $31 |
$25,512 |
|||
| Lilly USA, LLC |
$13,067
HUMATROPE $53 |
$13,014 |
||||
| Merck Sharp & Dohme Corporation |
$7,049
NON-PRODUCT $3,449 |
MK-0822 $300 |
$3,300 |
|||
| Janssen Research & Development, LLC |
$6,737
TOPAMAX $6,737 |
|||||
| Other |
$19,931
VERQUVO $2,650 |
SOLIRIS $1,842 |
AFREZZA $984 |
Minimed 670G System $369 |
Strensiq $283 |
Other $13,803 |
| Consulting Fee | $58,263 |
|---|---|
| Travel and Lodging | $23,343 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,550 |
| Food and Beverage | $4,153 |
| Grant | $500 |
| Other | $268 |
Dr. Linda A. Dimeglio, MD has received 433 research payments totaling $1,951,987.
Dr. Linda Dimeglio works as a general practice and pediatric endocrinology. Dr. Dimeglio accepts Anthem, Blue California, and Coventry, in addition to other insurance carriers. She speaks Spanish. Yext reports that she is accepting new patients at her office in Indianapolis, IN.